Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome.

Zuber J, Shonts B, Lau SP, Obradovic A, Fu J, Yang S, Lambert M, Coley S, Weiner J, Thome J, DeWolf S, Farber DL, Shen Y, Caillat-Zucman S, Bhagat G, Griesemer A, Martinez M, Kato T, Sykes M.

Sci Immunol. 2016 Oct;1(4). pii: eaah3732. doi: 10.1126/sciimmunol.aah3732. Epub 2016 Oct 7.

2.

Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice.

Foster AD, Soloviova K, Puliaeva I, Puliaiev M, Puliaev R, Finkelman F, Via CS.

J Immunol. 2011 Jun 1;186(11):6238-54. doi: 10.4049/jimmunol.1001074. Epub 2011 Apr 29.

4.

Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.

Chen H, Xu D, Qi S, Wu J, Luo H, Daloze P.

Transplantation. 1995 Apr 27;59(8):1084-9.

PMID:
7732551
5.

Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences.

Michalek J, Collins RH, Durrani HP, Vaclavkova P, Ruff LE, Douek DC, Vitetta ES.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1180-4. Epub 2003 Jan 16.

6.

Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.

Mannon RB, Kotzin BL, Nataraj C, Ferri K, Roper E, Kurlander RJ, Coffman TM.

J Clin Invest. 1998 Jun 1;101(11):2517-27.

8.

The cholinergic anti-inflammatory pathway delays TLR-induced skin allograft rejection in mice: cholinergic pathway modulates alloreactivity.

Sadis C, Detienne S, Vokaer B, Charbonnier LM, Lemaître P, Spilleboudt C, Delbauve S, Kubjak C, Flamand V, Field KA, Goldman M, Benghiat FS, Le Moine A.

PLoS One. 2013 Nov 21;8(11):e79984. doi: 10.1371/journal.pone.0079984. eCollection 2013.

9.

NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.

Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL, Dey B, McAfee S, Spitzer TR, Sykes M.

Exp Hematol. 2003 Oct;31(10):911-23.

PMID:
14550807
10.

Differences between graft-versus-leukemia and graft-versus-host reactivity. I. Interaction of donor immune T cells with tumor and/or host cells.

Rocha M, Umansky V, Lee KH, Hacker HJ, Benner A, Schirrmacher V.

Blood. 1997 Mar 15;89(6):2189-202.

PMID:
9058744
11.

Intragraft T cell receptor transcript expression in human renal allografts.

Pavlakis M, Lipman ML, Strom TB.

J Am Soc Nephrol. 1995 Aug;6(2):281-5.

12.

Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.

Wang XN, Haniffa MA, Holtick U, Collin MP, Jackson G, Hilkens CM, Holler E, Edinger M, Hoffmann P, Dickinson AM.

Transplantation. 2009 Jul 27;88(2):188-97. doi: 10.1097/TP.0b013e3181ac14ce.

PMID:
19623013
13.

Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation.

Johnson S, Qi S, Xu D, Jolicoeur M, Liu D, Barama A, Busque S, Smeesters C, Daloze P, Chen H.

Microsurgery. 2003;23(5):476-82.

PMID:
14558006
14.
15.

Intragraft distribution of lymphocytes expressing beta7 integrins after small bowel transplantation in mice.

Kellersmann R, Ulrichs K, Kellersmann A, Thiede A.

Transpl Immunol. 2004 Dec;13(4):249-58.

PMID:
15589737
17.

Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection.

Steger U, Denecke C, Sawitzki B, Karim M, Jones ND, Wood KJ.

Transplantation. 2008 May 15;85(9):1339-47. doi: 10.1097/TP.0b013e31816dd64a.

PMID:
18475193
18.

CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT.

Johnson BD, Konkol MC, Truitt RL.

Biol Blood Marrow Transplant. 2002;8(10):525-35.

20.

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.

Irschick EU, Hladik F, Niederwieser D, Nussbaumer W, Holler E, Kaminski E, Huber C.

Blood. 1992 Mar 15;79(6):1622-8.

PMID:
1547351

Supplemental Content

Support Center